Why is it in the news?
- The first WHO Global Clinical Trials Forum took place on November 20-21, 2023.
- Around 130 experts from 43 countries participated, representing a diverse range of perspectives and experiences in clinical research.
More about the news
- The forum aimed to bring together global experts to discuss and develop a comprehensive and sustainable vision for clinical research infrastructure.
- The primary goal was to enhance the capacity and capabilities of clinical research on a global scale.
- The discussions and initiatives were focused on aligning with the World Health Assembly resolution, ensuring that global clinical trials contribute effectively to public health goals.
- A key focus was on improving the quality and coordination of clinical trials, aiming for standardized practices and enhanced collaboration among researchers worldwide.
· Clinical trials are research studies designed to evaluate the safety and efficacy of medical treatments, interventions, or drugs in humans.
· These trials gather essential data on the effectiveness and potential side effects of new or existing treatments.
· The outcomes of clinical trials contribute significantly to the development of evidence-based medical practices, guiding healthcare decisions and treatment approaches.
Clinical Trials Registry – India (CTRI)
· The Clinical Trials Registry – India (CTRI) was established in 2007.
· It is maintained by the Indian Council of Medical Research (ICMR) under the Ministry of Health and Family Welfare.
· Every clinical trial conducted in India is required to be registered with CTRI before commencing.
· CTRI serves as a free online public record system for the registration of clinical trials, encompassing both public and private research initiatives.
Amendment to New Drugs and Clinical Trial Rules (2023)
· In June, the government passed an amendment to the New Drugs and Clinical Trial Rules (2023).
· The amendment permits researchers to utilize non-animal and human-relevant methods for testing the safety and effectiveness of new drugs. This aligns with global trends toward ethical and efficient research practices.